Loading…
Synthesis and biological evaluation of new [1,2,4]triazino[5,6- b]indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6- b]indol-3-ylthio-pyrimidines against Leishmania donovani
A series of [1,2,4]triazino[5,6- b]indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6- b]indol-3-ylthio-pyrimidines were synthesized and screened for their in vitro antileishmanial activity against Leishmania donovani. Among all, 8 compounds have shown more than 90% inhibition against promastigo...
Saved in:
Published in: | European journal of medicinal chemistry 2010-06, Vol.45 (6), p.2359-2365 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A series of [1,2,4]triazino[5,6-
b]indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6-
b]indol-3-ylthio-pyrimidines were synthesized and screened for their
in vitro antileishmanial activity against
Leishmania donovani. Among all, 8 compounds have shown more than 90% inhibition against promastigotes and IC
50 in the range of 4.01–57.78
μM against amastigotes. Compound
5, a triazino[5,6-
b]indol-3-ylthio-1,3,5-triazine derivative was found to be the most active and least toxic with 20- & 10-fold more selectivity (S.I.
=
56.61) as compared to that of standard drugs pentamidine and sodium stibogluconate (SSG), respectively.
[Display omitted] The triazino[5,6-
b]indol-3-ylthio-1,3,5-triazine derivative (
5) is the most potent and is 20-fold more selective, while triazino[5,6-
b]indol-3-ylthio-pyrimidine derivative (
20) is twofold more selective as an antileishmanial agent, in comparison with pentamidine. |
---|---|
ISSN: | 0223-5234 1768-3254 |
DOI: | 10.1016/j.ejmech.2010.02.015 |